David H. Richards

815 total citations
23 papers, 608 citations indexed

About

David H. Richards is a scholar working on Molecular Biology, Organic Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David H. Richards has authored 23 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David H. Richards's work include Asthma and respiratory diseases (4 papers), Respiratory and Cough-Related Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). David H. Richards is often cited by papers focused on Asthma and respiratory diseases (4 papers), Respiratory and Cough-Related Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). David H. Richards collaborates with scholars based in United Kingdom, United States and Australia. David H. Richards's co-authors include Valerie Lund, A.P. Sykes, Peter T. Daley‐Yates, Corey J. Wilson, Ian S. Mackay, Julian Rowe‐Jones, Stephen R. Durham, Robin Fears, Michael Tamm and Leonardo M. Fabbri and has published in prestigious journals such as Environmental Science & Technology, The Journal of Clinical Endocrinology & Metabolism and Annals of Neurology.

In The Last Decade

David H. Richards

22 papers receiving 567 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David H. Richards United Kingdom 14 187 169 159 157 102 23 608
Kerryn L. Simpson New Zealand 10 20 0.1× 70 0.4× 51 0.3× 53 0.3× 66 0.6× 10 571
Aimee Hoskins United States 11 9 0.0× 47 0.3× 173 1.1× 45 0.3× 76 0.7× 17 450
M. Cristina Tejedor Spain 14 47 0.3× 80 0.5× 94 0.6× 4 0.0× 149 1.5× 41 535
Serena Di Vincenzo Italy 18 15 0.1× 52 0.3× 154 1.0× 18 0.1× 368 3.6× 57 858
Mark B. Lampert United States 8 7 0.0× 351 2.1× 152 1.0× 14 0.1× 160 1.6× 12 936
I Grzelewska-Rzymowska Poland 12 9 0.0× 22 0.1× 190 1.2× 47 0.3× 70 0.7× 70 433
V. Ferrero Italy 11 125 0.7× 142 0.8× 25 0.2× 2 0.0× 127 1.2× 19 489
Alyson Connor United Kingdom 16 11 0.1× 141 0.8× 35 0.2× 16 0.1× 91 0.9× 27 806
Ulrich Sydlik Germany 15 11 0.1× 18 0.1× 65 0.4× 51 0.3× 230 2.3× 20 726

Countries citing papers authored by David H. Richards

Since Specialization
Citations

This map shows the geographic impact of David H. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Richards more than expected).

Fields of papers citing papers by David H. Richards

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Richards. The network helps show where David H. Richards may publish in the future.

Co-authorship network of co-authors of David H. Richards

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Richards. A scholar is included among the top collaborators of David H. Richards based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Richards. David H. Richards is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyd, Anita, et al.. (2023). A novel echocardiographic risk score for light-chain amyloidosis. European Heart Journal Open. 3(3). oead040–oead040. 5 indexed citations
2.
Richards, David H., et al.. (2016). Fourteen Ways to Reroute Cooperative Communication in the Lactose Repressor: Engineering Regulatory Proteins with Alternate Repressive Functions. ACS Synthetic Biology. 6(1). 6–12. 24 indexed citations
3.
Howell, Stanley C., David H. Richards, William A. Mitch, & Corey J. Wilson. (2015). Leveraging the Mechanism of Oxidative Decay for Adenylate Kinase to Design Structural and Functional Resistances. ACS Chemical Biology. 10(10). 2393–2404. 6 indexed citations
4.
Choe, J.K., David H. Richards, Corey J. Wilson, & William A. Mitch. (2015). Degradation of Amino Acids and Structure in Model Proteins and Bacteriophage MS2 by Chlorine, Bromine, and Ozone. Environmental Science & Technology. 49(22). 13331–13339. 40 indexed citations
5.
Tobin, Peter, et al.. (2014). Protein Engineering: A New Frontier for Biological Therapeutics. Current Drug Metabolism. 15(7). 743–756. 35 indexed citations
6.
Scadding, Glenis, et al.. (2014). Double-blind, placebo controlled randomised trial of medical therapy in otitis media with effusion.. 1(2). 58–68. 3 indexed citations
7.
Tamm, Michael, David H. Richards, Bianca Beghé, & Leonardo M. Fabbri. (2012). Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice. Respiratory Medicine. 106. S9–S19. 54 indexed citations
8.
Rowe‐Jones, Julian, et al.. (2005). Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray.. PubMed. 43(1). 2–10. 88 indexed citations
9.
Daley‐Yates, Peter T. & David H. Richards. (2004). Relationship between systemic corticosteroid exposureand growth velocity: development and validation of a pharmacokinetic/pharmacodynamic model. Clinical Therapeutics. 26(11). 1905–1919. 44 indexed citations
10.
Fink, R, et al.. (2002). Hypothalamic-Pituitary-Adrenal Axis Function after Inhaled Corticosteroids: Unreliability of Urinary Free Cortisol Estimation. The Journal of Clinical Endocrinology & Metabolism. 87(10). 4541–4546. 34 indexed citations
11.
Lund, Valerie, et al.. (1998). Effect of Fluticasone in Severe Polyposis. Archives of Otolaryngology - Head and Neck Surgery. 124(5). 513–513. 119 indexed citations
12.
Richards, David H. & Catherine M. Milton. (1996). Fluticasone propionate aqueous nasal spray: a well‐tolerated and effective treatment for children with perennial rhinitis. Pediatric Allergy and Immunology. 7(1). 35–43. 18 indexed citations
13.
Golding, Peter, Ross Millar, N. C. PAUL, & David H. Richards. (1995). Preparation of nitramine-nitrates by ring-opening nitration of azetidines by dinitrogen pentoxide (N2O5). Tetrahedron. 51(17). 5073–5082. 13 indexed citations
14.
Golding, Peter, Ross Millar, N. C. PAUL, & David H. Richards. (1993). Preparation of Di- and polynitrates by ring-opening nitration of epoxides by dinitrogen pentoxide (N2O5). Tetrahedron. 49(32). 7037–7050. 8 indexed citations
15.
Golding, Peter, Ross Millar, N. C. PAUL, & David H. Richards. (1993). Preparation of nitramine-nitrates by ring-opening nitration of aziridines by dinitrogen pentoxide (N2O5. Tetrahedron. 49(32). 7063–7076. 10 indexed citations
16.
Viguier, Michel, et al.. (1987). Polydienes possessing terminal ionic groups. Part 2. Preparation of polydienes with terminal borate groups. British Polymer Journal. 19(3-4). 241–246. 2 indexed citations
17.
18.
Fears, Robin & David H. Richards. (1981). The effects on lipoprotein metabolism of rats of glycerolipids substituted with 4-benzyloxybenzoic acid (BRL 14280). Biochemical Society Transactions. 9(6). 571–572. 3 indexed citations
19.
Newsome, P M, et al.. (1981). α2-Adrenoceptors controlling intestinal secretion. Biochemical Society Transactions. 9(5). 413–414. 3 indexed citations
20.
Richards, David H.. (1980). Catalyst Systems in Anionic Copolymerisations. British Polymer Journal. 12(3). 89–94. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kerryn L. Simpson Breakdown of academic impact, for papers by Aimee Hoskins Breakdown of academic impact, for papers by M. Cristina Tejedor Breakdown of academic impact, for papers by Serena Di Vincenzo Breakdown of academic impact, for papers by Mark B. Lampert Breakdown of academic impact, for papers by I Grzelewska-Rzymowska Breakdown of academic impact, for papers by V. Ferrero Breakdown of academic impact, for papers by Alyson Connor Breakdown of academic impact, for papers by Ulrich Sydlik
Rankless by CCL
2026